Surgical Case Reports (Feb 2023)

Surgical resection of a retroperitoneal liposarcoma producing insulin-like growth factor II: a case report

  • Noriyuki Nishiwaki,
  • Yoshihiro Mikuriya,
  • Fumiaki Takatsu,
  • Ryoji Ochiai,
  • Tomokazu Kakishita,
  • Naruyuki Kobayashi,
  • Takaya Kobatake,
  • Shinji Hato,
  • Norihiro Teramoto,
  • Mototsugu Nagao,
  • Izumi Fukuda,
  • Koji Ohta

DOI
https://doi.org/10.1186/s40792-023-01589-9
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Background Tumor-produced high molecular weight insulin-like growth factor-II (big insulin-like growth factor-II) is considered to cause non-islet cell tumor hypoglycemia. This paper presents a case of surgically resected retroperitoneal liposarcoma that produced big insulin-like growth factor-II. Case presentation Here, we report the case of a 62-year-old woman who presented with an abdominal mass and hypoglycemia. Non-islet cell tumor hypoglycemia due to retroperitoneal liposarcoma was suspected. After complete resection of the tumor, the patient’s hypoglycemia improved and big insulin-like growth factor-II disappeared in the molecular weight analysis of serum insulin-like growth factor-II by western blotting. The patient had no tumor recurrence or reappearance of hypoglycemia 16 months after the operation without any adjuvant therapy. Conclusions Although insulin-like growth factor-II-producing tumors are generally large and difficult to operate on, surgical resection is currently the most effective and only treatment; thus, it is essential to attempt resection aggressively.

Keywords